ivl tool treatment armamentarium initi
perform
shockwav intravascular lithotripsi ivl repres anoth tool clinician
armamentarium treat moder sever calcifi vascular lesion neutral
stanc predic follow exist clinic evid ivl mix
unclear ivl stand-alon adjunct therapi lack stand-alone
reimburs limit util street expect enthusiast
model factor compound-annual-growth-rate next two year revenu grow
stock recent high remain concern
street expect clinic trial well revenu trajectori
front henc initi rate perform
durabl impair antiprolif effect drug coat balloon treat
calcifi coronari peripher arteri therefor challeng date lack
true compar effect durabl outcom hinder proper
assess space especi pad oper prefer lucr
reimburs drive adopt necessarili long-term outcom
estim coronari pci procedures/year us use balloon
sever calcium case pad side estim
sever calcif preval pad complex diseas plu
fragment market provid fertil ground new therapi
shockwav ivl balloon util ultrasound shockwav creat microfractur
medial intim calcium endovascularli mechan thought
improv arteri complianc antiprolif drug uptak henc outcom
definit therapi stent dcb shockwav current
run two pivot trialsdisrupt pad-iii disrupt cad-iiiin
peripher coronari space respect
shockwav attempt answer question confess follow
thing remain unclear us vi -- vi clinic studi use predilat
postdilat determin increment benefit ivl
titrat ivl paramet particular lesion set technique-sensit
procedur optim
current ivl growth fuel inpati pad use us coronari
ou ivl account total drg code pci
pad set present challeng hospit time
rush earli adopt fade categori code essenti growth
year price histori
market
coronari
use
analyst certif import disclosur see disclosur
disrupt pad-iii success
disrupt-cad ii success
code receiv obl set
ivl anoth tool clinician armamentarium
unclear ivl use stand-alone adjunct
lack categori reimburs code limit util
dcb slowdown due late-mort signal problemat
use ivl inpati set higher normal
dcb slowdown pull ivl usag
advers event start pop ivl use
disrupt pad-iii cad-iii fail
tabl content
implic arteri calcif
challeng treat vascular calcif
challeng vessel prepar
vessel prep cad treatment
vessel prep pad
late mortal signal paclitaxel dcb
clinic evid ivl
reimburs econom ivl
vascular calcif cad-pad problem
vascular calcif coronari peripheri real problem
date lack true random control trial lack compar assess
outcom lack durabl outcom particular therapi yield
fragment marketplac especi pad oper prefer lucr
reimburs drive adopt necessarili long-term outcom moderate-sever
vascular calcif introduc anoth element complex far
test use orbit atherectomi calcif restrict vessel expans result
higher residu stenosi lower procedur effect durabl calcif
may impair antiprolif effect drug coat balloon dcb like act
physic barrier drug penetr addit calcif increas risk
embol restenosi percutan translumin angioplasti pta
market opportun treat calcifi arteri larg
vascular calcif coronari peripheri direct correl
age diabet obes exist evid indic patient year
age almost calcium least bed two-third calcif
coronari arteri bed time approxim cad patient also
concomit pad make total address market
appeal estim coronari percutan coronari intervent pci
procedur perform annual us almost involv combin plain old
balloon angioplasti atherectomi stent interestingli atherectomi use pci
us approxim total volum primarili use case
calcif problem total pci procedur volum moderate-sever calcium
estim preval rate sever calcium case
pad side estim endovascular procedur perform annual
us varieti mix-and-match approach stent dcb atherectomi etc
atherectomi use pad share sever calcif preval pad
estim lack definit approach treat calcifi cad
pad along lack durabl long term outcom make fertil ground
intravascular lithotripsi similar extracorpor lithotripsi reli shock wave creat
saline-fil balloon shock wave creat micro- macroscop fractur
medial intim calcium fractur creat thought increas local arteri
complianc therefor allow better stent expans drug elut stent de
procedur better drug uptak dcb procedur seen shockwav
studi disrupt cad disrupt pad etc real-world independ case studi
certain percentag ivl case requir predil certain percentag case
post-dil field check indic ivl view favor
enabl tool atherectomi stent dcb essenc ivl like
plain old balloon angioplasti poba albeit benefit sonic wave temporarili
chang arteri complianc facilit deliveri tool thu practic
purpos ivl special vessel prep balloon anoth tool clinician
armamentarium question realli key competitor ivlatherectomi
poba atherectomi lack compar reimburs becom
problem adopt poba sure support
asp ivl balloon
initi bodi evid ivl
shockwav conducted/i conduct numer post-market studi showcas
efficaci ivl coronari arteri disease/peripher arteri diseas cad/pad name
cad disrupt-cad ii disrupt-cad etc highlight report
collect bodi evid cad pad indic ivl facilit deliveri
anoth definit therapi whether drug elut stent de drug-coat balloon
dcb atherectomi exactli clear increment impact use
ivl exampl disrupt-pad ivl suppos evalu stand-
alon therapi predil use case post-dil use
case delin impact use noncompli balloon
higher pressur effect ivl disrupt-pad ii much said
optim techniqu ivl help improv primari patenc closer look reveal
post-hoc analysi intent-to-treat patient dispar
patient deem therapeut miss henc requir optim math
doesnt make sens us disrupt btk predil requir
case post-dil case disrupt-pad pivot studi evalu
ivl dcb poba dcb trial wait restart view suddenli face
percept battl given focu dcb definit therapi especi time
paclitaxel dcb seem consensu view emerg late mortal signal
disrupt-cad pivot studi on-going unclear us ascertain
increment impact ivl coronari critic look trial seem
suggest true competit posit ivl clear
numer unknown remain ivl
remain unclear us titrat shockwav algorithm particular lesion set
shockwav definit involv number variablesballoon size length
inflat time pressur puls frequenc type lesion cavit dynam
focal zone sever calcium etc point report one size fit
even real-world case studi direct seem predil prior
shockwav ivl dilat post-ivl use poba ivl note
higher pressur thu abil delin effect ivl poba could
becom almost imposs time sonic wave definit form
injuri creat injuri calcium caus fractur known collater
effect damag soft tissu time argument use ivl fractur medial
intim calcium henc allow better drug uptak back
literatur abl find histopatholog studi corrobor
complianc enabl definit therapi ivl alter
biominer process involv vascular calcif definit therapi
stent dcb deploy remain unclear us margin
improv outcom due ivl moreov case intim calcium remain
unclear us stent under-expans present extent thu
come back origin argument ivl special vessel-prep balloon
lack code could limit growth
shockwav ivl current understand use hospital-bas coronari
procedur outsid us ou peripher procedur us ivl note
stand-alon reimburs code view limit applic
office-bas lab obl set even current slate clinic trial provid
definit understand role ivl understand shockwav
origin made argument lack embol ivl therefor essenti
crippl chanc map atherectomi reimburs code
recent field check suggest attempt revers feel way
map exist code therein lie problem approach long term
initi burst usag wider adopt constrain due lack categori
reimburs code time note recent compani commentari
seem tout use ivl complementarili atherectomi devic coronari
peripheri impli lack broad util stand-alone basi question
ivl enabl definit therapi relat question
maintain price point current seem overal cost
buri diagnosi relat group drg payment system shockwav ivl
product cost current estim amount drg pci set
pad set without definit clinic proof worri high price
point unsustain
ivl repres anoth tool clinician armamentarium
treat moder sever calcifi vascular lesion aggress model
ramp rate given current enthusiasm field revenu go estim
prospect compound-annual-growth-rate howev contend
current util predic rapid use hospital-bas set
us ou unclear us sustain sinc ivl realli
special vessel-prep balloon payment process map
atherectomi reimburs code stock reflect near perfect execut
clinic trial front well revenu trajectori believ henc initi rate
base santa clara ca medic devic compani
manufactur market proprietari intravascular lithotripsi devic use
calcifi vessel either stand-alon therapi adjunct drug elut stent
balloon compani base file littl sale
repres consensu estim annual revenu stand around
treatment cad shockwav cathet ce mark european equival
fda approv indic use calcifi stenot de novo coronari arteri prior
stent treatment pad shockwav cathet ce mark
fda clearanc indic use calcifi stenot peripher arteri
shockwav present interest tool armamentarium coronari peripher
vascular diseas treatment abil modifi vascular calcif therefor
improv complianc clinic outcom
shockwav ivl system consist cathet hous ultrason emitt
enclos integr angioplasti balloon mount rapid exchang system
shockwav gener connector cabl gener recharg link
balloon cathet via connector cabl chip cathet provid necessari
lithotripsi deliveri paramet goal elimin need adjust paramet
on-site cathet distal proxim marker use place ivl balloon
within lesion activ miniatur lithotripsi emitt appli pulsatil
mechan energi along length diamet balloon
exhibit order shockwav ivl moa intravascular lithotripsi
shockwav ivl devic monorail balloon-bas cathet central core
deliv guidewir balloon vari length size rang
mm diamet chosen ratio rel target-vessel
refer diamet gener produc energi probabl
balloon apposit vessel wall ensur low pressur atm inflat use
salin contrast solut maintain therapi cycl ivl cycl
perform maximum eight cycl per devic area concern
recommend undergo minimum two cycl lithotripsi lithotripsi deliv
emitt vapor fluid insid s-ivl balloon creat expand
collaps bubbl gener sonic pressur wave acoust energi wave travel
vessel wall select fractur intim medial calcium high
shear stress creat balloon apposit thought critic facilit proper
energi transfer therefor ensur calcium modif increas vessel complianc
optim stent expans list regulatori statu specif usag
shockwav current product portfolio shown
specif indicationsregulatori statusshockwav diameterperipher vascular use fda lengthexclud carotid cerebr ce mark fr sheath puls max shockwav diametercalcifi de novo coronaryc mark lengtharteri cadongo global emittersenrol began earli fr guid puls max puls generatorcompact portablefor use shockwav ivl fda power supplycathetersc mark output diameterperipher vascular use fda lengthexclud carotid cerebr ce mark fr sheath puls max perform na
note variabl involv lithotripsi gener intravascular extracorpor
matter suggest follow variabl critic import
highlight optim extracorpor shockwav lithotripsi kidney stone
still on-going debat
prf rate shockwav sent across boundari prf directli influenc
cavit rate exampl fragment kidney stone numer
research paper highlight effect alter prp cavit dynam stone
fragment sourc mcclain et al review urolog volume sapozhnikov et
al acoust societi america volume etc note
differ intravascular litho extracorpor shockwav litho exist
question extracorpor litho might offer guid better analyz ivl exampl
kidney stone treatment author sapozhnikov et al highlight total exposur
physic mechan respons injuri seem suggest sort
cavit dynam involv
moreov aggreg bodi literatur suggest reduc prf improv
cavit dynam stone fragment mitig vessel trauma ivl
particular call compani indic peripher product
medium-s vessel sfa iliac arteri five emitt last year new
softwar launch ad addit puls product go
puls rational behind increas total puls avoid need anoth
cathet question arisesov period puls deliv
effect cavit dynam intens shockwav creat
collater damag dont know
cavit dynamicsfocu area size
inter-rel phenomenon process creation cavit
bubbl width bubbl acoust energi focal zone complet analysi
cavit dynam beyond scope report energi focal zone
respons trauma creat healthi tissu calcium crack
theoret appear present highest shear intens cavit
bubbl oct studi confirm fractur calcium vessel wall
remain unclear presenc collater damag vessel wall
intim respons shockwav manifest time
interestingli paper wong et al sourc journal invas cardiolog march
volume author make refer spike seen patient ecg
deliveri ivl offer two potenti explan first electr spark
creat fluid vapor ivl deliveri caus artifact pick
ecg second possibl direct link electrocardiogram
signal piezoelectr effect
graidi present hellen institut cardiovascular diseas
vascular calcif coronari bane pci procedur complic
deliveri therapi also final outcom vascular calcif shown
directli influenc age irrespect co-morbid develop
coronari calcium scale agtaston score along implement within diagnost
space led greater emphasi manag tackl problem vascular
calcif coronari interestingli enough adapt-d studi evalu use
drug-elut stent calcifi coronari arteri showcas widespread preval
calcium coronari author note approxim one-third coronari
patient popul moderate/sever calcif patient pool
sever calcium find coronari calcium also increas last
year due primarili incorpor accept coronari calcium score final
exhibit order preval coronari calcif trend coronari ca diagnosi sever ca pci
seen exhibit coronari vascular calcif preval vari
coronari bed vari degre howev age probabl direct correl
burden calcif exist evid indic patient year
age almost calcium least vascular bed two-third calcif
arteri bed term cad procedur volum analyz address
complet analysi variou specif kind coronari
heart diseas preval stratifi bed age gender level calcif beyond
scope report specif keep high level avoid get mire
exhibit order tam shockwav ivl coronariesu atherectomi use pciu
atherectomi use note calcifi lesion real question mind
shockwav ivl target toward poba market essenc make
special vessel prep balloon would ivl use lieu atherectomi
calcifi lesion current unclear bodi evid indic ivl
would posit vessel prep balloon
rise incid obes diabet age creat perfect storm peripher
vascular diseas also world-wide estim pad continu rise exponenti
treatment option chose usual mix-and-match given complex
diseas lack rigor compar studi approach specif
report stick market believ address shockwav ivl
current subscrib role ivl tavr evar transcathet aortic
valv replac endovascular aneurysm repair per se tavr primari concern
remain presenc distal emboli could potenti make outcom wors
current seen sapien corevalv evolut convers use ivl
evar least base understand market remain long shot henc
stick key target market ivlbelow knee btkinfrapoplit
knee atkfemoropolit approxim preval calcium stratifi arteri
locat pad shown
exhibit order overlap pad cad presenc calcium arteri locat
us estim pad patient roughli one-quart
claudic roughli endovascular procedur
current perform sourc shockwav approxim sort
calcifi lesion outsid us anoth pad procedur perform
world-wide pad market interestingli estim around us
anoth ou number includ kind balloon drug elut stent drug
elut balloon atherectomi devic modal drug elut balloon deb
far fastest-grow categori space howev march dear
letter fda cite late mortal signal paclitaxel coat balloon
put paus modal crimp compound-annual-growth-rate y/i low single-digit
remain unclear deb resum upward trajectori least fda
put confirmatori guidanc use deb
use drug elut stent de remain preval atk case despit concern
stent fractur overal outcom de improv year newer
stent design greater radial strength facilit use de combin
atherectomi all-in market pad stratifi use devic shown next
page calcul ivl remain somewhat problemat given ivl statu
vessel prep balloon lack clariti price sustain ivl balloon
procedur also number shown next page specif us includ
procedur done office-bas set estim obl set current
account two-third overal volum therefor ad anoth layer complex
proper analys ivl given lack obl reimburs ivl
exhibit order us pad market volum approx pad market mm distribut lesion type
devic geographi
vascular atherosclerot
nation review cardiolog medic scienc monitor
vascular calcif vc patholog respons toxic stimuli involv metabol
substanc and/or inflammatori cell histor vascular calcif consid
passiv process result ca ion exceed solubl tissu fluid
therebi induc precipit deposit hydroxyapatit crystal howev vc
format consid complex activ control intracellular molecular process
involv differenti macrophag vascular smooth muscl cell vsmc
osteoclast-lik cell similar bone format calcium essenti ion mani
metabol pathway includ regul heart rate contractil neuron
activ endocrin system paradox genesi vc although store
primarili bone teeth calcium intak diet uptak
proport dietari content therefor excess ca result dietari
allow regularli surpass diseas state storag compromis
exhibit order calcifi vessel mechan vascular calcif
calcium may accumul variou organ spleen liver kidney circulatori
system deposit arteri intima media may eventu lead
obstruct atherosclerosi alter serum ca level concert
oxid stress caus local gener hydrogen peroxid promot
differenti vascular smooth muscl cell vascular wall osteogen
phenotyp alter also associ signific loss endogen
bone format pyrophosph induc inhibitor osteopontin circul
inhibitor fetuin-a
underli pathophysiolog mechan result vc broadli describ
elev serum ca level induct osteogenesi inadequ
inhibit miner process migrat differenti macrophag
vsmc osteoclast-lik cell studi involv vc shown calcium
deposit arteri wall report nearli american year age
vascular calcif risk factor similar atherosclerosi
hypertriglyceridemia increas decreas hdl obes hypertens
potenti genet role medial vc propos wherebi gene mutat
regul vsmc extracellular matrix phosphat product protein promot vc
hypothes
exhibit mechan vascular calcif
catheter cardiovascular intervent
vessel calcif process may classifi accord histolog structur
anatom locat etiolog structur histolog deposit may
structur bone cartilag tissu may appear amorph form
depend vessel wall layer one speak tunica intima calcif
especi unrel atherosclerot plaqu atherosclerosis-unrel
calcif tunica media medial arteri calcif monckeberg type latter
also call calcif urem arteriolopathi affect arteriolar vessel wall lead
develop organ insuffici failur etiolog calcif divid
metastat dystroph former type occur concentr calcium
phosphat increas affect healthi tissu typic accompani
diseas hyperthyroid neoplasm etc latter type appear normal
concentr calcium phosphat damag necrot tissu
intim calcif common form calcium accumul particularli
person demonstr risk factor atherosclerosi develop also patient
suffer chronic hypertens osteoporosi calcium accumul initi
increas atherosclerot plaqu modifi lipid content pro-inflammatori cytokin
phosphat lipoprotein complex well foci necrosi
vitro studi shown pro-inflammatori cytokin oxid low-dens
lipoprotein monocyte/macrophag releas product promot osteogenesi
accumul calcium deposit vitro condit calcifi vascular
cell cvc subpopul smooth muscl cell osteoblast characterist
spontan form bone miner present atherosclerot plaqu may spontan
produc miner cluster local small lump histolog resembl
atherosclerot plaqu lesion origin heart valv cusp area densiti
calcif foci depend presenc stimul inhibitor calcium
accumul increas concentr transform growth factor beta tgf-b vitamin
warfarin increas number size calcif foci teleolog function
intim calcif may isol interrupt progress abnorm cellular
process therebi protect healthi adjac intima howev blood flow obstruct
stenot intim lesion may lead decreas organ perfus ischemia
dystroph calcif often affect aortic valv result long-standing
action mechan stress pro-inflammatori factor proven
connect tissu calcifi aortal valv stroma demonstr disturb organ
macrophag t-lymphocyt infiltr progress chang
cellular molecular analysi valv reveal osteoblastogenesi presenc
calcif vascular cell presenc chronic inflamm marker increas express
osteopontin bmp matur bone tissu
medial calcif widespread lower abdomin region primarili
associ peripher arteri diseas result osteogen differenti
vascular smooth muscl cell within medial layer vessel wall ca
accumul begin amorph miner deposit undergo progress
remodel ultim miner matur bone although medial calcif
gener associ lumin obstruct decreas arteri wall elast
complianc may ultim lead atherosclerosi reduc perfus eventu
coronari peripher arteri diseas intens calcium-phosph accumul
occur muscl layer blood vessel patient diabet chronic renal
diseas proven advanc medial arteri calcif connect
increas risk sudden cardiac death lower limb amput due vascular
insuffici diabet free oxygen radic induc develop chronic
inflamm adventitia lead infiltr connect tissu macrophag
t-lymphocyt
hyperglycemia glycosyl end product increas product tumor necrosi
factor tnf-a osteopontin opn increas express
gene express particularli aris adventiti myofibroblast
opn aris muscl cell tunica media inflammatori mediat stimul
prolifer osteogen differenti migrat myofibroblast tunica media
result thicken remodel calcif layer end-stag renal
diseas excess calcium phosphat ion stimul osteogen differenti
via signal pathway inorgan phosphat stimul vsmc
differenti cvc activ sodium-depend phosphat transport
subsequ cascad pathway import role
calcif attribut metalloproteinas mmp secret
inflammatori cell adventitia tunica media caus increas elastin
metabolit turn activ monocyt thu intensifi inflammatori
process degrad product may becom crystal nucleat
initi format crystal nuclei
implic arteri calcif
vc describ previou section activ complex process
involv numer mechan respons calcium deposit arteri wall
lead increas arteri stiff puls wave veloc turn increas
cardiovascular diseas morbid mortal
mean arteri complianc base case studi shown rang
ml/mmhg healthi adult ml/mmhg heart failur patient arteri stiffen
well-known phenomenon caus factor includ age race vascular
calcif hypertens high salt intak exact chang arteri complianc
due vascular calcif alon studi although invers relationship
well-accept document anecdot
exhibit arteri complianc perfus
arteri complianc elast import concept physiolog perspect
primari rational arteri complianc energi storag smooth
variat arteri circuit specif exampl cardiac side
compliant aorta store energi systol releas diastol flow
peripheri continu throughout cardiac cycl vessel rigid pipe
forward flow would occur eject period
one-third cardiac cycl state otherwis blood pressur would time
higher period maintain output stiffen central arteri like aorta
crucial differ physic properti compar physiolog compliant arteri
translat complet differ hemodynam profil cardiovascular system
cardiac cycl
energi power gener left ventricl systol regard
sum blood volum replac stroke volum pressur increment
systol blood pressur complianc compart replac
 aorta declin energi compris pressur workload instead
volum due lack capac dilat physiolog situat part energi
transfer left ventricl store elast expans central arteri structur
stiffen central arteri possibl initi lead increas
systol pressur declin peripher blood suppli latter lead increas
left ventricular load eventu hypertrophi second physic featur stiffen
arteri increas veloc pressur wave gener systol
open aortic valv import differenti pressur wave
actual propag blood volum aorta latter much slower sinc
pressur wave reflect smaller arteri peripher arteri system
travers back opposit direct blood flow stiffen arteri
reflect pressur wave reach aortic root earlier eventu arteri stiffen
progress close peak pressur cardiac cycl augment peak
pressur central arteri induc increas cardiac afterload
addit trigger develop left ventricular hypertrophi
exhibit arteri elast clinic impact
puls pressur pp defin differ systol blood pressur
diastol blood pressur pp progress increas age due decreas arteri
complianc attribut calcif arteri wall multipl prior epidemiolog
studi shown increas pp correl cardiovascular morbid
mortal studi author hypothes puls pressur would strong
predictor aortic calcif
studi author identifi patient aortic pp measur cardiac
catheter non-contrast chest ct scan evalu presenc
calcium differ segment ascend aorta arch aorta descend aorta
quantifi patient calcif calcifi group compar patient
without calcif noncalcifi group term pp calcif complianc
result show mean total calcium score higher descend
aorta arch ascend aorta vs vs respect pp
strongest correl calcif descend aorta
calcifi group much higher pp noncalcifi group greatest
differ descend aorta mmhg lesser ascend aorta
mmhg least arch mmhg calcifi group
patient also much lower complianc noncalcifi group patient
greatest differ among group seen descend aorta ml/mmhg
follow ascend aorta arch snapshot result shown
exhibit order comparison mean aortic complianc subgroup use peripher puls pressur
associ calcium score invas aortic puls pressur
author make follow observations/hypothes
heterogen pattern thorac aortic calcif multipl mechan
propos includ alter low-density-lipoprotein cholesterol transport
increas turbul wall shear stress especi locat
descend aorta mani branch segment
instanc ascend aorta two branch right left coronari arteri
arch three branch brachiocephal right subclavian right common
carotid howev descend aorta multipl branch includ pair
posterior intercost arteri multipl arteri origin anteriorli includ
bronchial mediastin esophag pericardi branch well superior
phrenic arteri larger chang pp complianc observ patient
calcif descend aorta aortic segment direct
correl degre calcif chang pp arteri complianc
stratifi data group without calcif show presenc
calcif associ increas pp segment aorta
greatest signific chang observ descend aorta
decreas complianc seen differ segment aorta due presenc
calcif comparison two group one calcif one
without group gener lower complianc relationship
statist signific descend thorac aorta
median survival/follow-up time year mean rang
patient die calcif descend aorta
calcif either ascend aorta arch aorta
morbid mortal
arteri calcif directli implic increas morbid mortal
effect vc significantli pronounc patient diabet chronic
kidney diseas highlight one studi involv chronic kidney diseas ckd
make point vc amplifi outcom specif cohort patient studi
author blacher et al enrol ckd patient hemodialysi three
month clinic cardiovascular diseas six month
preced entri mean follow-up month data mortal obtain
entir cohort whose averag age time inclus year
follow-up patient continu form hemodialysi
one attribut includ analys arteri calcif
univari analysi also perform impact calcif cardiovascular
mortal presenc vc measur ultrasonograph common carotid
arteri abdomin aorta iliofemor axi leg highli echogen plaqu produc
bright white echo shadow consid calcif assess
presenc calcif complement post-anterior later fine-detail
radiograph abdomen pelvi arteri calcif femorotibi arteri
axi evalu soft-tissu nativ radiograph arteri calcif arteri
site quantifi absent present final score obtain
addit calcif studi zone final score rang absenc
calcium deposit calcif present arteri segment examin
calcif score independ check observ good reproduc
exhibit probabl all-caus surviv accord calcif score
follow-up month cardiovascular non-cardiovascular
death occur univari multi-vari analys show presenc
arteri calcif increas common carotid arteri increment elast modulu
einc strongli independ predict outcom end-stag renal diseas
esrd author specif design studi determin causal
relationship arteri stiff atherosclerosi howev found
strong intercorrel paramet relat atherosclerosi burden
calcif score paramet relat arteri stiff common
carotid arteri einc although close relat paramet
increment predict valu term cardiovascular all-caus mortal beyond
signific interact two paramet
effect paramet constant whatev level author
admit method quantifi calcium burden rather crude one
like underestim true calcium load graphic depict all-caus surviv
accord calcium score shown
challeng treat vascular
sourc singh et al evtoday raghid et al annal vascular medicin
surgeri parikh et al cleveland clinic journal medicin mori et al jacc
vascular calcif regardless vascular bed alway signific
challeng procedur success treat pad limit durabl intervent vc
also gener marker global atherosclerot burden studi market
cardiovascular morbid mortal numer challeng understand
treat vc remain includ
limit understand calcium pad
continu grow bodi evid multipl pathway implic
vascular calcif pathway complex interrel involv endocrin
inflammatori hormon metabol process vascular calcif
biolog activ diseas process repres dead tissu
diffus tissu calcif aris patholog condit lead systemat
genet autoimmun disord etc intim calcif atherosclerosi
associ patchi pattern calcif calcif featur advanc
plaqu may quit extens lead develop occlus diseas
consist relationship plaqu size complex degre
calcif calcif deposit promin plaqu older individu
abdomin aorta coronari arteri atherosclerot plaqu calcif enhanc
plaqu stabil decreas clinic event medial calcif hand
observ infanc character increas arteri stiff puls
pressur patient diseas remain asymptomat unless complic
atherosclerosi calciphylaxi arteri calcium deposit increas distal arteri
tree moreov medial calcif rel diffus vari wide degre
burden medial calcif caus stiffen arteri wall elast complianc
lead atherosclerosi reduc perfus peripher arteri diseas
cardiovascular mortal among patient especi end-stag renal diseas
multipl modal use non-invasive invas assess
calcif varieti vascular bed coronari arteri calcium score use ct
angiographi tool well accept predict futur cardiovascular event
peripheri ct mri highli sensit method assess degre extent
vascular calcif howev imag modal use contrast agent iodin
contrast ct gadolinium contrast mri associ potenti
nephrotox ct expos patient ioniz radiat ct angiographi
therefor remain import diagnost tool intravascular ultrasound
hand also wide avail measur degre extent calcium burden
howev ivu wide use uniform reimburs
associ expens fluoroscopi anoth tool use measur vc
howev underestim extent locat calcif superfici femor
arteri sfa particularli knee tibial arteri discrep
differ modal lack uniform framework assess calcium burden
complic proper understand type treatment impact particular
treatment peripheri though current understand calcium score driven
prospect adjud outcom data need develop calcif score
prospect data guid appropri therapi gener rule agre
heavier degre calcium burden greater impact procedur success
clear though rel impact medial vs intim calcium calcium
burden rel outcom
impact procedur success
exist literatur suggest calcif translat higher rate acut
procedur failur due vessel recoil and/or dissect requir adjunct
stent although adjunct stent repres acut procedur failur
evalu patient long term appear adjunct stent impact
patenc year vs drug coat balloon alon howev data deriv
small-pati cohort still complet understand whether
spot stent area acut recoil and/or dissect oppos appli full-met
jacket appropri therapi address drug coat balloon failur
variou stimuli initi progress calcif may differ
depend upon stage plaqu well surround milieu intim
calcif coronari death vascular smooth muscl cell drive
forc behind microcalcif medial calcif peripheri loss inhibitor
miner mainli promot calcif along osteogen mechan involv
bone form protein interestingli enough degre calcif might
differ implic treatment coronari vs peripheri coronari
plaqu type complex increas greater degre lumin narrow
preval extent calcif coronari arteri calcif shown
higher preval diabet patient wherea medial calcif shown
higher preval chronic kidney diseas patient
event rate base cardiac calcium score standard test call
agatston test shown previou exhibit studi base patient
interest mani level coronari calcium strongli associ advers
outcom popul far better marker futur event risk
equat date clear though howev whether relat
calcifi plaqu sourc event whether calcifi plaqu predict
presenc coronari diseas accur perhap crucial clinic question
regard coronari calcium score whether presenc predict plaqu
instabl stabil combin coronari imag patholog shown
type calcif locat extent well volum densiti
differenti effect clinic risk outcom gener spotti calcif seem
predict plaqu instabl coronari wherea heavi calcif correl
overal plaqu burden import studi coronari calcif studi
coronari calcium volum associ increas cardiovascular risk although
level calcif calcium densiti invers associ risk state
otherwis heavi calcium densiti might indic stabl fibrou cap
intima therefor provid degre plaqu stabil
predict event rate peripheri hand total spin roulett
wheel calcium score tool also lack quantifi imag
modal along higher preval medial calcif make calcium burden
assess problemat unlik cardiac calcium score evolv
rel better score mechan marker outcom peripher calcium score
virtual non-exist moreov prospect studi could find
specif talk impact calcif outcom pad
challeng vessel prepar
term lumin gain plaqu modif use first form vessel
prepar howev introduct use drug-coat balloon term
vessel prepar seem appropri encompass method therapi
lead lumin gain plaqu modif also enhanc efficaci
dcb especi use calcifi lesion superfici femor arteri
sfa poplit arteri goal vessel prepar includ remov calcif
modifi plaqu gain lumen dcb may efficaci deliv
drug vessel wall calcium particular deserv special consider may limit
vessel expans caus injuri drug effect develop
leave-nothing-behind strategi vessel prepar key focu
intervent dedic pretreat lesion mandatori plaqu modif
import come local drug deliveri lesion via either balloon stent
adequ lesion pretreat enhanc drug penetr vessel wall
promot increas antirestenot properti
sever calcifi arteri benefit drug-coat balloon dcb less distinct
due mechan barrier arteri wall challeng overcom
dedic vessel prepar atherectomi scoring/cut balloon angioplasti
addit mechan vessel prepar affect procedur success rate
long-term outcom consequ vessel prepar shift trend
consist element treatment algorithm vessel prepar minim risk
dissect maxim lumin gain prepar vessel bed stent vascular
mimet implant and/or local drug deliveri vessel prepar consid
regardless whether lesion stenot occlus especi crucial calcium
present today vessel prepar consist unders balloon predilat
angioplasti score cut balloon atherectomi score cut balloon
may consid calcifi fibrot lesion rational behind technolog
entir forc focus wire blade edg mount balloon
setup lead control plaqu incis control dissect less barotrauma
entir lesion score cut balloon may first consider bifurc
ostial lesion intent minim expect plaqu shift
exhibit outcom long vs short balloon inflat time
journal vascular intervent radiolog volume
everi balloon angioplasti creat certain extent vessel injuri larger dissect
prevent microdissect occur balloon-bas intervent
lack scientif data perform standard balloon angioplasti
perform vari medic specialti vessel local person
experi even day week zorger et al sourc journal vasc interv
investig influenc inflat compar inflat
demonstr procedur success endpoint bailout stent incid
major dissect need intervent favor long inflat
time signific dissect infrainguin balloon angioplasti remain
activ area debat dedic measur tool accur defin
stent-bas approach prefer infrainguin arteri calcium
biggest challeng success outcom although sever differ attempt score
amount distribut calcium establish none entir accept
challeng vessel prep approach though remain mention
dispar pre-procedur approach muddl proper comparison
uniform definit vessel prep simplest sens vessel prep
process chang arteri complianc allow full dilat without aggress balloon
inflat either dcb nondrug simpl poba balloon technolog stent
effect dilat vessel way vessel expand reliev obstruct
stent place depend oper discret vessel prep
dcb era gain traction sens allow full dilat lesion
dcb full coverag without signific dissect frank perfor
mitig need stent endovascular intervent goal
minim dissect recoil therebi optim result angioplasti
increasingli howev new technolog re-emphas central role vessel
prep optim outcom result case surpris
exampl recent trial dcb technolog demonstr patenc poba
better histor expect attent paid long low-pressur inflat
similarli outcom nitinol stent also like better adequ vessel
prepar optim prepar allow nomin stent deploy without area
under-expans stent elong sophist techniqu atherectomi
use specialti balloon score focal forc cut balloon
also improv outcom studi compar standard therapi without
dcb procedur vessel prep definit ar studi suggest
atherectomi silverhawk turbohawk long lesion calcifi
vessel might add benefit dcb
trial patient success predil without dissect
perfor enrol therefor presum outcom base
devic also degre predil select larg number
patient presum success predil clearli real-
world approach given real world predil necessari actual
intervent either way mani observ seem infer outcom base data
without consid patient enrol criteria predil becom critic
oper review data tri maintain evidence-bas approach
patient
type devic use vessel prep
choic vessel prep devic balanc devic safeti
potenti add efficaci current standard second consider
base whether oper experi use vessel prep devic
mani vessel prep devic bit difficult handl compar standard
pta balloon standard nitinol stent oper need feel comfort use
devic also learn curv differ type vessel prep devic
data valu vessel prep spars
robust data true valu vessel prepar spars valu
thrombectomi local thrombot occlus prior angioplasti stent
unquest even without larg studi differ thrombectomi devic
commerci avail select specif devic usual guid individu
oper prefer devic avail specif countri region
type vessel prep eccentr vs concentr lesion
anoth complic factor choic tool use vessel prep
direct atherectomi devic use treat eccentr lesion lithotripsi
concentr calcifi lesion unclear
answer question vari depend ask clinician use dcb
first dcb postdilat spot stent necessari done
case patient vessel prep might consid major need
vessel prep obviou analyz initi angiogram perform
intervent simpl noncalcifi focal lesion may benefit aggress vessel
prep form debulk devic vessel prep also necessari lesion
respons predilat mainli short fibrot stenot lesion tasc ii
indirect evid random dcb trial indic standard dcb angioplasti
preced standard balloon angioplasti probabl suffici
role vessel prep drug uptak
role vessel prep alter local drug deliveri complex one due interplay
lesion prepar drug deliveri develop restenosi avail
atherectomi devic provid benefit optim lumin gain either modifi
complianc vessel remov plaqu drug deliveri larger biolog
question whether devic also improv retent and/or depth drug
deliveri lesion question preliminari data devic suggest
better paclitaxel penetr vessel wall atherectomi whether
intervent reduc subsequ rate restenosi remain seen import
real studi point increas drug uptak plaqu
modif reason may due drug get wash dcb
inflat along drug get lost balloon deliveri lesion
site therefor leav rel littl drug transfer lesion lack
lipophil site sever calcifi lesion mean drug like paclitaxel least
theoret true bind site henc fractur calcium necessarili lead
increas drug uptak also remain unclear final drug uptak heavili
influenc type balloon inflat pressur drug excipi residu drug content
durat inflat hold time number inflat site
vessel prep devic tailor lesion type
imposs predict platform work best certain clinic scenario basic
cut balloon score balloon flex score cathet lithotripsi short lesion
best treat atherectomi eccentr lesion direct atherectomi longer
lesion flex cathet lithoplasti unclear
cost-effect data regard specialti balloon atherectomi devic
spars two major potenti area cost off-set includ reduc need stent
implant due dissect recoil could prevent improv
vessel prep potenti reduc rate target lesion revascular tlr
time studi need show benefit vessel prepar prior dcb angioplasti
sfa stent justifi addit cost specialti devic
long term data effect vessel prep
although acut result debulk vessel prep appeal question remain
increment benefit durabl superior inflammatori cost plaqu
remov effect current devic lumen gain
vessel prep cad treatment
vessel prep coronari predominantli involv prep vessel either use balloon
angioplasti atherectomi facilit stent placement report dcb
approv coronari remain seen paclitaxel sirolimu
drug choic coronari unlik peripheri paclitaxel drug
choic focu attent basic need vessel prep
vessel prep facilit improv outcom coronari stent intravascular imag
last year emerg necessari modal prior stent assess
coronari stenosi sever lesion make-up numer tool develop
ivu oct ffr uniqu advantag disadvantag
moreov readout intravascular imag might lead heterogen lesion
assess differ oper comprehens descript modal
pro con beyond scope report imag shed light
fundament question prior definit intervent stenosi signific
culprit lesion vulner plaqu likelihood
distal embol periprocedur mi stent implant optim
acut stent result thrombosi restenosi occur stent
exhibit recommend intravascular imag physiolog techniqu cad
vessel prep coronari primarili design address issu stent
malapposit vs underexpans underexpans refer size stent
wherea malapposit refer contact stent vessel wall influenc
acut chronic outcom post deploy bm de ivu predictor
earli stent thrombosi in-stent restenosi isr underexpand stent
inflow/outflow track diseas signific plaqu burden edg stenosi etc stent
malapposit long stent well expand although bigger better regard
stent expans less respect stent edg plaqu burden accept
procedur endpoint minimum stent area stent-edg plaqu burden
maxim probabl long-term patenc snapshot view caus stent failur
base variou studi intravascular imag help guid therapi shown
exhibit
exhibit caus stent failur
challeng treat calcifi coronari lesion rel higher non-
calcifi lesion studi point coronari calcif present
pci case sever calcifi increas coronari calcif lead higher
advers event procedur failur due un-dilat lesion balloon ruptur vessel
dissect pci vessel ruptur perfor asymmetr malappos
underexpand stent also remain huge issu sever calcifi coronari lesion
seen outcom horizons-ami acuiti coronari calcium
studi patient incid mace directli correl sever calcium
frequenc restenosi tlr peri-procedur mi likelihood stent
exhibit stratifi calcium sever horizonsami acuiti coronari calcium studi
anoth key consider coronari stent remain stent underexpans
correl calcium load import exist literatur point greater
arc length thick calcium greater likelihood stent underexpans
calcium arc therefor present interest conundrum use ivl
quantifi calcium arc use ivl correl benefit ivl use
variou calcium arc clinic outcom shown exhibit stent expans
invers correl calcium arc
exhibit stent expans correl calcium arc
anoth key concept pci stent stent recoil balloon underexpans
stent deliveri system use semi-compli balloon manufactur
chart certain balloon certain pressur turn give idea nomin
diamet inflat pressur howev balloon certif done either air
water therefor usual factor resist arteri wall exampl
calcifi lesion arteri wall complianc definit poor therefor present
high resist deliveri balloon fulli inflat balloon underexpans
turn lead subsequ stent recoil under-deploy remain debat
extent stent recoil larger diamet vs smaller diamet arteri
studi shown smaller bore arteri may result greater balloon
underexpans larger bore arteri interest studi author et al
sourc heart volume prospect angiograph studi
conduct lesion patient undergo pci stent quantit coronari
angiographi qca use measur minim lumen diamet deliveri
balloon stent deploy stent segment follow balloon
deflat snapshot balloon underexpans stent recoil shown
exhibit order deliveri balloon underexpans balloon/vessel ratio stent recoil
major find studi post-deploy stent minim lumen diamet
less predict manufactur complianc chart despit use
high inflat pressur stent deliveri balloon underexpans rel
complianc chart stent elast recoil result anoth mld reduct
balloon underexpans stent recoil similar irrespect refer vessel
diamet use higher inflat pressur semi-compli balloon could stretch
arteri wall balloon margin increas risk perfor vessel
dissect howev whether predilat prior stent improv final lumen
diamet post-stent remain seen studi rodriguez et al sourc
cardiolog volume author note stent recoil balloon deflat
account loss acut lumen gain angioplasti
orbit ii studi prospect multicent non-blind trial evalu safeti
efficaci orbit atherectomi use diamondback made
cardiovascular system modifi calcifi coronari lesion prior stent placement
studi enrol patient key inclus criteria target vessel refer
diamet stenosi stenosi
evid clinic ischemia via posit stress test ffr reserv
valu ivu minimum lumen area target lesion length
fluoroscop ivu evid sever calcium deposit requir total length
calcifi portion least patient exclud target
vessel stent previou pci recent mi chronic renal failur lvef
use thrombectomi therapi embol protect devic brachytherapi
cut balloon allow primari efficaci endpoint defin procedur
success defin stent deliveri residu stenosi without occurr
in-hospit mace primari safeti endpoint mace day defin
compromis mi tvr cardiac death secondari endpoint includ angiograph
success facilit stent deliveri residu stenosi without sever
angiograph complic index procedur well rate individu sever
complic perfor persist slow flow persist reflow abrupt closur
index procedur
exhibit order primari efficaci endpoint orbit ii primari safeti endpoint orbit ii
primari efficaci safeti outcom highlight stent deliveri
success case less residu stenosi case in-
hospit mace mi rate present tct
princip investig present side-by-sid comparison orbit ii angiograph
complic rel boston scientif rotobl seen sever dissect
use diamondback perfor rate slow flow persist no-
reflow abrupt closur spasm etc number compar
favor exist literatur rotobl howev note caution
warrant make comparison sinc head-head studi control
exhibit angiograph complic orbit ii compar rotobl literatur
orbit ii lower rate in-hospit non-q wave q-wave mi
respect author also compar result publish literatur
rotobl stratifi calcium score specif studi point includ one
mosseri et al show rotobl non-q wave mi rate
studi referenc one clavijo et al studi sever calcifi lesion treat
de without rotat atherectomi found non-q wave mi ck-mb
uln rate rotat atherectomi de group rate
des-onli group mortal rate compar orbit ii abovement
studi sever calcifi lesion point favor outcom orbit atherectomi
compar rotobl tlr rate orbit ii compar rotobl tlr
rate mosseri studi clavijo studi
author conclud
orbit atherectomi met primari safeti efficaci endpoint signific margin
orbit ii studi
improv might relat orbit atherectomi uniqu mechan
subsequ analys orbit-ii shown orbit atherectomi cost-effect
durabl clinic year follow-up safeti efficaci benefit seen orbit ii
maintain year supplement cost-effect therapi per
publish report chamber et al scai exhibit showcas
longer term result
exhibit order two-year safeti data orbit ii efficaci data
vessel prep pad
perhap one age-old mysteri treatment peripher arteri diseas
remain use vessel prep prior definit therapywheth stent angioplasti
dcb highlight variou vessel prep technolog note
convinc data vessel prep truli confer superior outcom endovascular
procedur acut result use debulk plu stent dcb vs debulk alon seem
quit appeal visual angiogram howev key question remain
outcom durabl superior vessel prep ration bodi evid
suggest definit studi done across therapi
across standard lesion set know sure vessel prep make durabl
differ endpoint across trial dispar patient select bia widespread
long-term follow-up non-exist studi name issu despit
issu cite vessel prep continu activ use pad treatment especi
leave-noth behind strategi employ last year
logic vessel prep pad base belief minim dissect maxim
lumin gain prepar vessel bed stent vascular mimet implant and/or
balloon angioplasti pad use sinc earli said
fascin note standard techniqu develop poa
date typic poba involv inflat plain balloon atm pressur certain
durat typic balloon usual overs rel arteri
depend oper prefer techniqu use stretch arteri near
lesion therefor increas acut lumen gain use stent
dcb use everi balloon angioplasti creat level barotrauma vessel injuri
vessel dissect frequent occurr depend type lesion
particular poba algorithm employ microdissect occur either way especi
calcifi lesion howev larger dissect prevent sinc requir
emerg stent open vascular surgeri earli elast recoil frequent dissect
poor primari secondari patenc rate long lesion case requir
bail-out stent limit balloon angioplasti sever calcifi lesion sourc
exhibit balloon angioplasti pad
interest studi zorger et al vasc interv radiol author evalu
impact balloon inflat time acut outcom poba peripheri
key takeaway studi prolong poba inflat time reduc
dissect sever rate therefor reduc need intervent
result highlight exhibit next page significantli fewer major
dissect modest reduct residu stenosi observ
exhibit impact balloon inflat time outcom
anoth studi fujihara et al sourc journal endovascular therapi volume
author util retrospect data registri show increas
sever sfa dissect neg correl primari patenc rate
freedom tlr presenc chronic total occlus lesion length
composit well durat follow-up affect outcom note though
retrospect registri henc conclus view
framework necessarili definit data studi vessel dissect
link poba use type dissect outcom data seem
indic poba result grade dissect higher
exhibit order dissect type poba dissect impact clinic outcom
fujihara et al journal endovascular therapi kobayashi circ cardiovascular intervent
atherectomi procedur perform debulk atherosclerot plaqu diseas
arteri usual combin low-pressur balloon angioplasti goal
minim plaqu shift avoid stent placement dens calcifi vessel
atherectomi use better prepar vessel prior stent order
prevent incomplet and/or eccentr stent expans differ atherectomi
devic design cut shave sand vapor atherosclerot calcifi plaqu
slightli differ indic depend lesion characterist
atherectomi tool differ mechan action requir differ skill set
sweet spot certain lesion set differ impact outcom
rel basi broadli speak four differ atherectomi tool direct
atherectomi rotat atherectomy/aspir laser ablat orbit atherectomi
direct atherectomi devic util carbid rotat cutter disk resect
remov atherosclerot plaqu devic advantag avoid
barotrauma may decreas risk neointim hyperplasia dissect distal
embol remain concern devic given devic requir
retriev remov plaqu use distal protect devic may need
particularli case heavili calcifi lesion silverhawk turbohawk
covidien/medtron plaqu excis system two fda-approv direct
atherectomi devic use today
hawkon system also introduc simplifi devic select allow
treatment lesion differ morpholog includ sever calcif one
devic determin effect silverhawk peripher plaqu excis
treatment infrainguin vessels/low extrem definit le studi
evalu direct atherectomi safeti efficaci claudic patient
us europ post-atherectomi bail-out stent rate rate distal
embol dissect perfor respect
month primari patenc rate claudic wherea rate freedom
major unplan amput target limb month subject
boston scientif jetstream atherectomi system single-us cathet
reusabl compact consol power sourc front-cut tip allow go
stenot lesion without predil atherectomi devic offer continu
aspir activ remov atherosclerot debri thrombu thu devic
may particularli use lesion mix morpholog particularli
presenc thrombu acut subacut occlus excim laser atherectomi
philip use high-energi monochromat light beam alter dissolv vapor
plaqu without damag surround tissu devic includ turbo elit
ablat cathet well turbo-tandem system combin laser guid cathet
excim laser atherectomi cathet
laser angioplasti critic limb ischemia laci trial critic ischem
limb above- below-kne diseas poor candid surgic
revascular treat excim laser-assist intervent limb-salvag
rate six month sourc laird et al endovasc ther volume
excim laser advantag debulk also abl penetr
proxim fibrou cap chronic total occlus thu may advantag
util intent enhanc cross capabl well debulk
occlud vessel result excim laser random control studi
treatment femoropoplit in-stent restenosi excit isr trial patient
demonstr safeti efficaci excim laser atherectomi femoropoplit in-
fewer procedur complic compar pta dissect
embol bailout stent excim laser plu pta versu pta-onli
patient six-month freedom target lesion revascular tlr versu
orbit atherectomi diamondback similar one describ vessel prep
coronari atherectomi devic eccentr mount crown
use reduc total atheroma burden decreas vessel-wal trauma
particularli calcifi vessel orbit atherectomi util diamond-co tungsten
crown orbit degre eccentr within vessel employ
circumferenti plaqu remov differenti sand confirm registri seri
evalu use orbit atherectomi peripher lesion lower extrem
show effect reduc degre stenosi use
adjunct low-pressur balloon angioplasti complianc trial compar
acut result patient orbit atherectomi plu pta versu
pta calcifi femoropoplit diseas sourc dattilo et al invas cardiol volume
month freedom tlr restenosi achiev lesion
group despit rare use bail-out stent atherectomi vs
pta peri-procedur advers event seen infrequ orbit
atherectomi perfor dissect embol
despit differ choic atherectomi devic advanc technolog
compar efficaci safeti studi evalu fda-approv devic
atherectomi devic reduc burden soft atheromat calcif plaqu
chang vessel complianc reduc vessel wall trauma lead decreas
need bail-out stent hand atherectomi devic carri significantli
higher capit equipment-rel cost particularli use conjunct distal
protect filter lead increas procedur durat exposur radiat
given avail multipl atherectomi devic day-to-day clinic practic
import initi obtain expertis singl devic pay attent patient/les
select whether util distal protect
score cut balloon variant poba microsurg nitinol blade
atherotom bond longitudin surfac balloon microsurg
blade balloon inflat make intent score vessel lesion allow
increas vessel complianc better stent expans presum moreov
score balloon lower inflat pressur compar poba therefor
expect less vessel injuri henc lower restenosi typic
score balloon mechan action shown exhibit
exhibit order typic balloon moa poba moa balloon
typic score balloon local injuri score site therefor potenti reduc
trauma control dissect less slippag therefor medial layer
visibl disrupt endotheli layer remain intact convers poba result
multipl rip tear media endothelium get damag case
lead hematoma and/or neointim injuri cut balloon rel expens
higher profil difficult navig tortuou anatomi given stiffer natur
balloon
clinic evid cut balloon vs poba mix best result
global trial sourc mauri et al american journal cardiolog volume
multicent random trial patient test hypothesi surgic
dilat use cut balloon cb patient could result less arteri trauma
fewer dissect less frequent restenosi convent poba patient
lesion select studi simpl type lesion treat singl
cut balloon inflat balloon-arteri ratio control dilat
cut balloon reduc rate angiograph restenosi compar
convent poba cb compar poba coronari
perfor occur cb arm compar result
global trial indic cb angioplasti simpl lesion superior
convent prevent restenosi
restenosi cut balloon evalu trial rescut multicent
random prospect european trial includ patient type isr
found group major isr lesion shorter
mm length restenot stent similar cut balloon cba mm
ptca mm number balloon use treat isr lower cut
balloon group one balloon use cba case compar
procedur balloon slippag less frequent cba group cba
 trend toward lower need addit stent
cba group cba ptca seven-month angiograph follow-
binari restenosi rate differ group cba
 similar pattern recurr restenosi clinic event seven
month also similar
similarli data cut balloon small vessel ostial bifurc lesion
mix complet descript variou trial posit side neg
side beyond scope report howev note essenc cut balloon
creat defin crack intim calcium lack superior durabl
outcom poba long-haul interest note unclear
score element design inflat time pressur zone
score type lesion lack physiolog benefit plaqu
modif use score implic intravascular lithotripsi fascin
dcb newest tool armamentarium peripher interventionalist
background dcb import understand pharmacokinet
drug elut restenosi work dcb rel de also given recent fda
guidanc document increas late mortal signal paclitaxel dcb like
de address sever complex sometim contradictori requir
ensur balanc drug retent transfer lesion effect
drug transit vessel wall optim drug uptak net drug uptak
combin type drug type excipi type vessel bed characterist
balloon coat process schemat typic dcb shown
exhibit order dcb mechan role excipi
paclitaxel current drug choic dcb given long histori use
rel well-understood pharmacokinet highli lipophil molecul paclitaxel
high propens bind lipophil center vascular wall act -globulin
level impair microtubular assembl interrupt cell cycl drug uptak
ptx shown influenc follow
degre crystallin
differ form ptx use dcbsamorph crystallin hybrid
crystallin ptx coat shown studi releas particl
amorph coat howev studi shown despit releas
particl lumen crystallin form allow better transfer ptx drug
rel higher retent vessel wall sourc
excipi solvent agent help protect ptx matter limu
analogu wash drug prematur univers realiti dcb
type excipi extent mitig drug loss time
dcb fulli inflat ideal excipi allow remain drug
transfer vessel wall therefor maxim drug avail target site
main excipi use current paclitaxel-co dcb urea polysorb
sorbitol butyrl-tri-hexyl citrat polyethylen glycol among other pie chart
approxim depict final locat ptx drug use dcb
import analyt perspect
exhibit approxim drug distribut dcb deliveri
current literatur indic irrespect type excipi drug coat
process total drug load dcb eventu avail transfer
target lesion roughli drug get wash lumen balloon
inflat leav avail transfer vessel wall number
critic import note sinc whole notion increas drug uptak ivl
vessel prep mean increment drug uptak would singl digit
henc question aris increment uptak clinic signific moreov
calcifi lesion mean result lipophil bind site target lesion less
henc even drug avail would drug bind lesion
homogen drug coat process
homogen drug coat process becom critic import drug uptak
differenti proxim distal side part current dcb
homogen distribut ptx across length dcb
interest studi author fanelli et al sourc cardiovascular intervent
radiolog volume author sought ascertain impact vascular
calcif efficaci dcb revascular sfa lesion studi
patient sfa occlus stratifi accord ca burden group
lost balloon transfer inc
ca burden group group group lesion
length pact balloon use patient
recommend inflat time use key primari endpoint
late lumen loss lll defin minimum lumen diamet hour
procedur minu lumen dia post-procedur measur duplex
ultrasound primari patenc pp defin freedom restenosi duplex
base psvr tlr result primari endpoint shown
exhibit late lumen loss primari patenc stratifi calcium sever quadrant length dcb
author conclud follow dcb effect lower patient higher
degre calcium vs late lumen loss higher higher calcium
sever vs primari patenc declin higher calcium
advers event vs implic conclus drug uptak
presum affect calcium sever although note
real studi conduct evalu differ drug uptak use histopatholog
poba dcb stent human
interest studi author granada et al sourc open heart volume
mechan tissu uptak retent paclitaxel evalu porcin
coronari model use taxu stent crystallin paclitaxel-co dcb
amorph paclitaxel coat dcb quantit histopatholog done use tag
paclitaxel identifi tissu uptak pk profil one hour follow balloon inflat
formul achiev similar arteri paclitaxel level vs ng/mg
 ns hour cc maintain similar tissu concentr wherea ac
tissu level declin time point arteri level cc
ac time higher compar pe group day arteri
level retain cc ac baselin level paclitaxel
concentr vessel surfac higher cc vs
day vs addit cc induc higher
level neointim inhibit fibrin deposit delay heal compar ac
exhibit order ptx tissu level crystallin ptx dcb cc amorph ac taxu stent
late mortal signal paclitaxel dcb
pursuant meta-analysi publish katsano et al sourc
fda march
issu dear letter essenti highlight risk late mortal signal
and-paclitaxel-elut letter state three trial paclitaxel coat devic
follow-up data show higher mortal subject treat
paclitaxel-co product subject treat uncoat devic total among
subject trial approxim increas risk
mortal subject treat paclitaxel-co devic versu treat
control devic versu crude risk death year subsequ
fda held advisori committe meet june discuss avail
evid fda conduct analysi came conclus
higher later mortal signal paclitaxel exhibit repres late mortal data
adcom meet
exhibit late mortal signal ptx-coat devicesdata present fda adcom meet
consensu view adcom panel fact increas late
mortal signal paclitaxel coat devic fda final recommend sourc
accept increas late mortal signal paclitaxel patient
inform increas risk addit clinic evid develop assess
long-term safeti paclitaxel coat devic
clinic evid ivl
complet numer small-scal studi pad cad
fair number player space embark pretti much
path term get regulatori clearanc first realli tri valid safeti
efficaci true random fashion highlight studi shockwav
undertaken far also note trial give us complet pictur
rel exist treatment modal pad cad space
disrupt pad feasibl studi done determin safeti efficaci ivl
calcifi fempop arteri stand-alon therapi studi patient
calcifi stenot de novo femoropoplit arteri lesion prospect enrol
shockwav ivl balloon size refer vessel diamet inflat
atm puls deliv follow dilat nomin pressur
procedur repeat provid minimum puls target lesion per vessel
segment interv deflat allow distal perfus inclus criteria includ
moder sever calcif refer vessel diamet stenosi
lesion length mm patent runoff vessel foot exclus criteria
includ rutherford categori untreat signific inflow diseas signific
renal diseas dialysi procedur angiogram along duplex ultrasound
discharg day month analyz core lab
primari perform endpoint procedur success defin post-treat
residu diamet stenosi without adjunct percutan angioplasti
per core laboratori loss vessel patenc defin restenosi duplex
ultrasound core laboratori review major advers event assess day
month defin emerg surgic revascular target-limb amput
thrombu distal emboli requir treatment perforation/ flow-limit dissect
requir intervent includ stent function outcom includ improv
ankl brachial index rutherford categori assess month initi
stenosi averag lesion length mm calcium burden
signific sever calcif report patient averag calcifi
length balloon deliv success patient requir use
pre- post-dil procedur success occur patient
final residu stenosi acut gain mm averag
number puls mean balloon pressur mm hg averag treatment
time minut per patient vascular complic index procedur
adjud core laboratori stent implant distal embol filter
use discret investig total case thrombu
present filter vessel patenc day month
respect tlr within month major advers event report
month author conclud ivl success treat calcifi stenot
fempop lesion dramat reduct stenosi sever high acut gain
key question aris mind
studi design evalu ivl stand-alon therapi pre-dil
use time post-dil use case
unclear us overlap pre-dil post-dil
lesion differ lesion
wouldnt pre-dil post-dil introduc new variabl term vessel wall
injuri lumen gain sinc use compliant non-compli poba higher
pressur doesnt pre-dil post-dil negat argument stand-alon
therapi specif patient
distal embol filter use one case distal thrombu found
contrari core argument distal embol henc safe
disrupt padii studi prospect open-label multi-cent safeti
efficaci studi design evalu safeti perform shockwav ivl
system subject moder sever calcifi peripher arteri
rvd target site sixti patient enrol trial follow-up requir
day month month index procedur primari safeti endpoint
includ composit new-onset mae primari efficaci endpoint
target lesion patenc duplex ultrasound defin freedom
stenosi baselin lesion characterist note
exhibit lesion characterist disrupt pad ii
post-hoc analysi use parc criteria done core lab util prospect
collect angiogram interestingli enough studi protocol call addit
lithotripsi puls deliv target lesion use angiograph guidanc obtain
optim reduct diamet stenosi pre-dilat small diamet standard pta
cathet allow event ivl cathet could cross lesion post-
dilat allow ensur optim result provision stent allow
address sever dissect high-grad residu stenosi
snapshot procedur outcom shown exhibit next page
interest compar metric rel disrupt pad exampl mean
number puls use disrupt pad disrupt pad ii mean
number puls similarli pre-dilat use case
disrupt pad compar post-dilat use case
disrupt pad compar disrupt pad ii mean treatment time
disrupt pad minut unclear metric disrupt
exhibit procedur outcom disrupt pad ii
interestingli enough post-hoc analysi complet core lab use
prospect collect data assess optim devic techniqu optim techniqu
defin correct balloon size avoid therapeut miss balloon size
calcul ratio ivl balloon rvd ivl balloon rvd ratio defin
correct balloon size ivl balloon unders subject therapeut miss
defin failur provid full lithotripsi overlap segment proxim
distal lesion locat therapeut miss occur subject result
post-hoc optim ivl analysi shown
exhibit comparison outcom post-hoc subgroup analysi optim ivl techniqu
key question come mind
much made optim ivl techniqu improv patenc
seen month post-hoc analysi wasnt prospect defin
reliabl would data base arbitrari definit optim
optim techniqu analysi perform patient primari patenc
month cohort highlight public brodmann
et al base definit correct balloon rvd ivl balloon size
post-hoc analysi show balloon unders patient moreov
therapeut miss occur patient dont know
patient/pati therapeut miss balloon unders
separ patient patient separ addit
patient includ post-hoc analysi optim techniqu
bring anoth question patient base optim techniqu
patenc month overal patient cohort
primari patenc month patient definit
primari patenc much lower
final clear idea public extent calcium
arc sever differ cohort optim techniqu cohort
brodmann et al journal endovascular therapi volume
disrupt btk studi prospect non-random multicent feasibl
studi safeti efficaci ivl therapi patient below-the-kne critic
resultsoptim primari freedom tlr perform na
limb ischemia primari safeti endpoint composit major advers event
mae day defin death mi need emerg revascular
target limb amput target limb primari effect endpoint acut
reduct percentag diamet stenosi target lesion baselin characterist
patient studi shown
exhibit patient baselin patient characterist disrupt btk studi procedur characterist
brodmann et al journal endovascular therapi volume
length calcium burden greater lesion length vs
anterior posterior tibial arteri one commonli treat studi
ivl cathet deliveri fail patient infrapoplit procedur complic
adjunct therapi predilat post-dilat stent place
residu stenosi none flow-limit dissect averag ivl cathet
per patient use treatment averag lithotripsi puls
deliv outcom studi shown
question studi
predilat requir case post-dilat requir
influenc step final outcom compliant
non-compli balloon use pressur inflat
level lumen gain alreadi influenc use adjunct therapi
ivl cathet abl cross one lesion case
percentag case normal heavili calcifi vessel would requir sort
devic and/or atherectomi tool open proxim cap
number ivl puls appli lesion site physician discret
averag number puls appli direct correl
lumen gain ivl puls deliv
final stent place count procedur failur
ratio rvd ivl balloon state henc compar protocol rel
disrupt pad disrupt pad ii possibl
disrupt pad prospect multi-cent singl blind rct studi ivl dcb
vs poba dcb moder sever calcifi fempop lesion total subject
random enrol studi site across europ new
zealand shockwav cathet use studi design
demonstr optim therapi dilat heavili calcifi fempop lesion demonstr
benefit ivl combin dcb vs type equat dcb alon
patient follow procedur success defin residu stenosi
without flow-limit dissect grade prior dcb stent angiograph
core lab secondari outcom measur includ primari patenc defin freedom
cdtlr freedom restenosi determin duplex ultrasound
composit unplan target limb major amput symptomat thrombu distal
emboli requir surgic mechan pharmacolog mean improv flow clinic
success abi clinic success rutherford categori clinic success qualiti life
typic inclus criteria rutherford categori target limb lesion de novo
sfa poplit arteri rvd diamet target lesion
investig visual estim target lesion part treat zone
lesion length total target lesion calcif
least moder defin presenc fluoroscop evid calcif parallel
side vessel extend length lesion lesion
length extend minimum lesion length typic exclus
criteria rutherford categori plan target limb major amput
histori prior endovascular surgic procedur index limb past
plan within index procedur mi stroke within enrol
addit rct observ studi disrupt pad os
subject meet inclusion/exclus criteria object
patient observ studi assess real-world acut perform
shockwav cathet stand-alon adjunct therapi dcb
stent atherectomi studi endpoint includ procedur success in-hospit ae
procedur success defin residu stenosi prior dcb stent
angiograph core lab inclus criteria observ studi femor ilio-
femor poplit infra-poplit arteri claudic rutherford class
target limb calcif least moder parallel side vessel
extend length lesion lesion length extend
minimum lesion length
total patient enrol disrupt padiii studi along
disruptpad os studi compani expect increas
enrol os studi abl find preliminari data
pad ii lesson world registri present on-line data
patient disrupt pad os present patient
enrol time present patient baselin characterist
present
exhibit patient characterist disrupt pad osinterim data
holden et al studi statu disrupt pad ii lesson world registri
approxim lesion sever calcifi parc definit
procedur perspect data look fascin view approxim one-third
lesion requir pre-dilat half requir post-dilat number ivl
puls given much higher disrupt pad ii btk stand-alone ivl
use case adjunct therapi requir henc
true clinic util disrupt pad os studi interim data
headscratch increment value-add ivl given confound variabl
exhibit order lesion characterist disrupt pad os procedur characteristicsinterim data
holden et al studi statu disrupt pad ii lesson world registri
author holden et al present showcas slide us confus
best shown exhibit next page graph show acut result
disrupt pad ii disrupt pad os interim studi author state
despit complex calcifi lesion all-com studi acut result
first patient os studi compar favor disrupt pad ii studi
exhibit comparison across disrupt pad ii disrupt pad osinterim data
holden et al studi statu disrupt pad ii lesson world registri
rais follow question graph
disrupt pad os interim data repres adjunct therapi
use case henc increment valu therapi
one interpret acut result use mix-and-match approach
translat increment efficaci particular devic
use predilat post-dilat rais red flag
clinic util econom perspect
final disrupt pad ii use ivl stand-alon vs disrupt pad os
mix-and-match henc graphic depict insinu
valu ivl seem littl confus us
disrupt cad feasibl studi assess perform safeti
lithoplasti patient mean age year men moder sever
calcifi arteri vessel diamet mm stenosi forty-eight
percent cohort angina classif class ii subset patient
analyz oct patient follow day month primari
safeti endpoint major advers cardiac event includ mi transcathet
aortic valv replac cardiac death post-pci clinic success defin residu
stenosi evid in-hospit mace primari perform
endpoint dr brinton also founder present data
feasibl studi europcr
patient clinic devic success defin effect devic
deliveri lithoplasti treatment target lesion percent diamet stenosi
decreas procedur final angiographi acut gain
final angiographi mm two patient grade dissect
lithoplasti final angiograph complic day three
patient experienc non-q-wav mi month rate mace
includ cardiac death non-q-wav mi subgroup patient
analyz oct research found mechan vessel expans
circumferenti calcium fractur analysi also confirm stent expans high
lumin acut gain high amount calcif
disrupt cad ii prospect non-random multicent post-market studi
demonstr safeti perform coronari ivl cathet heavili calcifi
lesion prior stent studi understand finish
enrol patient center across europ trial protocol call use ivl
follow de endpoint includ in-hospit mace cardiac death
procedur success defin residu stenosi stent in-hospit
mace oct sub-studi patient includ
disrupt cad prospect non-random open-label multicent studi
demonstr safeti efficaci shockwav ivl system use cathet
heavili calcifi coronari lesion prior stent studi
approv fda requir approv use coronari lesion
studi enrol patient across global center europ clinic
data expect primari endpoint number particip
treatment devic relat mace within day index procedur mace
defin cardiac death mi defin ck-mb level uln valu without
new patholog wave tvr defin revascular target vessel inclus
target lesion complet index procedur number
particip success index procedur without in-hospit mace
success procedur defin deliv lithotripsi target vessel place
coronari stent residu stenosi core lab assess without in-hospit
key question disrupt cad come mind
rel clinic util ivl open-label non-random singl arm studi
difficult ascertain
unclear us kind protocol use disrupt cad respect
sonic puls treatment time type stent use post-ivl use pre-dilat
post-dilat
short-term studi focus acut perform ivl even
somehow abl accur measur acut perform ivl
coronari real result long-term outcom disrupt cad
compar disrupt cad orbit ii
first world experi coronari
wong et al journal invas cardiolog volume march
author wong et al report real-world experi use ivl patient
requir coronari stent patient enrol octob
januari therefor make single-cent studi relev baselin
characterist patient shown
exhibit baselin patient characterist first real-world experi ivl coronari
wong et al journal invas cardiolog volume march
angiograph success defin achiev residu stenosi edg
dissect thrombolysi myocardi infarct timi flow procedure-rel
in-hospit complic death mi target-vessel failur record primari
procedur outcom abil deliv ivl balloon success deploy
desir stent success clinic outcom defin stent deliveri without
procedur in-hospit complic indic pci ac patient
stabl angina patient treatment tavr patient
among ac case total receiv ivl infarct-rel arteri
index procedur stage pci sever non-culprit lesion up-front ivl
use intervent cardiologist case rest use
inadequ predil balloon angioplasti pre-specified intravascular
author report
shockwav ivl balloon could deliv patient stent deliveri
achiev patient major intraprocedur complic
three patient asymptomat non-q wave myocardi infarct
report mace day
ivl balloon larg deliver sometim requir ancillari support
impact long-term heal target lesion failur yet determin
potenti strategi shockwav use would option predil
mm compliant non-compli balloon deliv shockwav therapi facilit full
stent expans adequ plaqu modif deliv stent
post-dil non-compli balloon lesion requir aggress
predil one shockwav pass
rais follow question public
disrupt cad real-world studi report non q-wave mi patient
ivl therapi stent
paper specif state lesion length number puls given
seem durat treatment rvd ivl balloon size
studi use definit angiograph success residu stenosi
disrupt cad ii use residu stenosi differ logic
would dictat residu stenosi would correl better long-term
author wong et al also propos use predilat post-dilat strategi
ivl use respect total case requir post-dilat
ivl use stent question introduc ishow much
neointim injuri introduc due poba use higher pressur much
final efficaci outcom poba rather ivl dont know
conduct feasibl studi use ivl pre-tavr frankli
speak see logic ivl pre-tavr notwithstand ad cost
current dont understand measur aortic regurgit pre-tavr use
patient slate get tavr procedur
reimburs econom ivl
one fundament issu shockwav stori notion
reimburs lack thereof remind shockwav ivl use
predic devic eko lysu micro-infus indic use
us current lithotripsy-enhanc balloon dilat lesion includ calcifi
lesion peripher vasculatur includ iliac femor ilio-femor poplit
infrapoplit renal arteri use coronari cerebr vasculatur
sourc fda bring key
question reimburs code applic use ivl either
coronari peripher set note categori reimburs code
ivl current interestingli enough shockwav follow comment
made specif reli local deliv sonic pressur ivl
safe modifi intim medial calcium without caus perfor
distal embol damag vasculatur surround tissu believ
reduc complic physician also abl reduc number addit
devic requir success complet treatment patient
understand base due dilig call key clinician field
notion creat distal embol fact seem counterintuit
impact potenti dedic reimburs code seem view ivl
essenti balloon lack physic remov
materi vasculatur provid distinct ivl atherectomi
make case safeti ivl understand argument may
inadvert rightli made ivl atherectomi tool henc
atherectomi code applic discuss compani
highlight us current usag peripheri us driven
inpati usag due primarili lack code
summari key drg code pad cad procedur shown tabl
follow present summari variou relev code note
applic ivl especi outpati set
common practic use variou medic devic inpati use mask
util within drg code henc instruct pars differ
compon typic procedur work seen syntax studi
typic index pci procedur use de cost somewher rang up-front
stage game go lifetim analys qali etc exercis
futil given clear understand valu proposit ivl
direct cost account overal pci procedur hospit cost
account undertak exercis profit analysi essenti
look cost associ inpati procedur net profit
drive util especi initi euphoria die
seen index pci cost bare profit hospit inpati
set least base current medicar rate state otherwis isnt much room
maneuv cad set ad devic increment cost
atherectomi tool given primari consider use pci case
us ad ivl balloon pci procedur necessit elimin
atherectomi devic complet reduct index procedur time substanti
reduct index hospit time stage given life-cycl
unclear us ivl fit within econom paradigm
coronari procedur doesnt mean wont use select case mean
workhors product wide adopt need shift underli
mechanicseith valu proposit proven definit asp
product come clinic outcom drastic differ
current standard care none seem plausibl scenario current
exhibit order index pci procedur cost coronari bm de comparison cost vs reimburs
split cost pad side shown next page seen index cost
pad depend cocktail treatment use rang anywher
poba atherectomi stent reimburs procedur
interestingli rang aforement number
inpati set net differenti import directli play adopt
new therapi unlik outpati set lot overhead cost
present rel reimburs lot favor inpati set
render indiscrimin usag new therapi servic without proven
benefit henc ivl growth rate within pad go continu long-term remain
seen especi given lack dedic code
exhibit order index pad inpati procedur costspoba dcb atherectomi
comparison cost vs reimburs
jacc volume clinicoecon outcom jour vascular surgeri volume
rel player cad pad space newcom
product regulatori approv variou geographi mention
note revenu split almost use pad
us cad outsid us ou respect shockwav ivl cathet
assum approxim model assumpt sure
time could shift given level adopt coronari
peripheri depend strength clinic data time believ
number safe assumpt also note poba price
rang dcb rang de rang
atherectomi devic rang quarterli comparison
shockwav possibl current given exact inform quarterli revenu
stratif avail made best guess revenu split
base regulatori approv publicli avail inform
deliber stay away revenu stratif vessel type util
rate simpli kind inform probabl never go releas
compani exercis stratifi revenu thu would exercis gigo
theori base compani report us account overal sale
y/i growth us market driven hospital-bas usag
cathet sfa large-bor iliac access ou revenu constitut
overal revenu y/i growth sure law small number
rel earli stage compani skew growth rate ou growth
driven hospital-bas usag coronari cathet dichotomi interest
note bound chang time experi gain
on-going trial come fruition
key consider financi model price sustain shockwav ivl given
lack code sure product use drg set long
hospit will absorb cost approxim total drg
set pci pad set extent drg accommod
special vessel-prep balloon demonstr improv outcom believ
growth continu belief reflect pro forma model
everi reason base current evid believ shockwav ivl least safe
help vessel-prep whether margin improv outcom unknown
shockwav updat sale market headcount therefor extent
current sg spend best guesstim sg percentag sale account
model increas level sg spend next
year grow ratio percentag
sale goe spend remain rel high given
plethora clinic trial work spend estim
final key attribut trend gross margin gross margin stood
approxim estim go assum ivl price point
toler marketplac extent shockwav squeez addit
margin gain allow compani spend market effort gain
greater share pci pad market said envis
compani reach profit least time latest
doug join shockwav chief execut offic may lead compani
us commerci intern expans follow recent tenur
ceo director heartwar leader lvad market manag
organ pre-commerci phase sale acquir
august prior heartwar mr godshal held
execut leadership posit includ presid vascular
surgeri divis member boston sci oper committe vice presid
busi develop respons transact mani
arena coronari peripher intervent ceo earn mba
northeastern univers ba econom lafayett colleg
puckett join april compani chief financi
offic recent serv cfo counsyl venture-back dna test
genet counsel compani mr puckett cfo ariosa
diagnost molecular diagnost compani acquir roch came
ariosa forest laboratori serv execut director oper
cerexa forest laboratori subsidiari prior cerexa mr puckett held senior financ
oper posit affymetrix inc aol bhp billiton ltd earn
univers san francisco ba degre account washington
dr join shockwav may chief medic offic prior shockwav
serv global chief medic offic execut vice presid boston scientif
corpor well member execut committe
role follow time boston scientif cardiolog rhythm vascular
group join senior vice presid
associ chief medic offic cardiovascular busi earlier career dr
practic intervent cardiologist year
earn seri clinic research academ distinct includ post-
doctor research fellowship stanford univers fulbright scholar serv
presid british cardiovascular intervent societi bci held numer
appoint hospit region nation committe includ nation
institut clinic excel author
academ public present varieti cardiac topic dr
earn first class honor degre patholog london univers guy hospit
train cardiolog oxford royal brompton st georg hospit
initi coverag perform rate shockwav
intravascular lithotripsi repres anoth tool clinician armamentarium treat
contrarian street view specif believ follow exist clinic
evid ivl mix best paint complet pictur unclear
ivl stand-alone adjunct therapi chang equat term
util reimburs stand-alone basi remain achil heel
stori base lack embol logic almost inconceiv map
atherectomi code pure engin perspect remain unclear us
ivl outcom superior atherectomi long haul
aggress model ramp rate given current enthusiasm field howev
contend current util predic rapid use hospital-bas set
us ou unclear us sustain sinc
clear idea compar ivl toa plain old balloon atherectomi
devic expect shockwav call near perfect execut clinic
trial front well revenu trajectori henc initi rate perform
risk stori execut risk reimburs risk competit risk market
stock price compani mention report
nyse outperform cover steven lichtman
number
sale
sg
number
properti plant equip
accumul comprehens incom
